- Report
- July 2022
- 85 Pages
Global
From €1784EUR$2,000USD£1,534GBP
- Report
- July 2022
- 40 Pages
China
From €2854EUR$3,200USD£2,454GBP
- Report
- February 2022
- 106 Pages
Global
From €1784EUR$2,000USD£1,534GBP
- Report
- May 2021
- 50 Pages
China
From €2319EUR$2,600USD£1,994GBP
- Report
- April 2021
- 40 Pages
China
From €2319EUR$2,600USD£1,994GBP
- Report
- September 2026
Global
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
Global
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
United States
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
North America
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
Europe
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
Middle East
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
Asia Pacific
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
United States
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
United Kingdom
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
North America
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
Europe
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
Middle East
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
Asia Pacific
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
China
From €3559EUR$3,990USD£3,060GBP
- Report
- September 2026
Europe
From €3559EUR$3,990USD£3,060GBP

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally.
The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more